Quick Answer
Pterostilbene Sleep Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Reduced estradiol levels have been associated with undesirable symptoms of the menopause transition.
Key Takeaways
- 01Reduced estradiol levels have been associated with undesirable symptoms of the menopause transition. [Holmes HE (2026)]
- 02As anticipated NRPT intake significantly increased urinary levels of methyl-nicotinamide (Me-NAM) as well as the methylated pyridone carboxamides (Me-PYs) in all groups. [Holmes HE (2026)]
- 03Introduction Nicotinamide adenine dinucleotide (NAD+) is a metabolite of vitamin B3 necessary for the production of key hormones like estradiol. [Holmes HE (2026)]
- 04Type 2 diabetes mellitus (T2DM) affects approximately 10-25% of patients undergoing orthopedic procedures and is associated with impaired tissue healing, increased complication rates, and reduced responsiveness to orthobiologic therapies, including platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), and mesenchymal stem cell (MSC) preparations. [Santos MDS (2026)]
The current Migaku evidence database contains 2 reusable source documents for Pterostilbene Sleep Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts.
- Reduced estradiol levels have been associated with undesirable symptoms of the menopause transition. [Holmes HE (2026); evidence level 2]
- As anticipated NRPT intake significantly increased urinary levels of methyl-nicotinamide (Me-NAM) as well as the methylated pyridone carboxamides (Me-PYs) in all groups. [Holmes HE (2026); evidence level 2]
- Introduction Nicotinamide adenine dinucleotide (NAD+) is a metabolite of vitamin B3 necessary for the production of key hormones like estradiol. [Holmes HE (2026); evidence level 2]
- Type 2 diabetes mellitus (T2DM) affects approximately 10-25% of patients undergoing orthopedic procedures and is associated with impaired tissue healing, increased complication rates, and reduced responsiveness to orthobiologic therapies, including platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), and mesenchymal stem cell (MSC) preparations. [Santos MDS (2026); evidence level 4]
- Emerging, predominantly mechanistic evidence suggests that targeted nutritional interventions, including bioactive compounds targeting mitochondrial biogenesis pathways, anti-inflammatory dietary patterns, and specific micronutrients, may modulate these pathological processes and potentially improve orthobiologic outcomes. [Santos MDS (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources
- Nicotinamide riboside and pterostilbene reduces frequency and severity of undesirable symptoms of the menopause transition: an open-label, pilot clinical trial.
- Nutritional Interventions to Optimize Orthobiologic Therapy Quality in Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Framework: A Narrative Review.